Irena Adkins

Irena Adkins

Company: SOTIO Biotech

Job title: Science Pharmacology Lead

Seminars:

Group Panel Discussion: Next Steps: From Concept to Therapy – Considerations for Successfully Applying Strategies Learnt To Optimize Your Cytokine Therapy 5:30 pm

The importance and practical implications of optimizing toxicity, dosing, scheduling & related considerations – how far have we come & what do we need to remember when designing cytokine therapies Tips, pitfalls & lessons learnt from optimizing toxicity & dosing Considerations for cytokine delivery design/methods/concepts Developing a biomarker alongside a therapy – how should we…Read more

day: Day One

SO-C101, a High-Affinity IL-15Rbg Agonist, Which Induces Safe & Potent Anti-Tumor Immune Activities in Patients with Solid Tumors & Supports Further Clinical Investigations 4:00 pm

• Understanding SO-C101 is a high affinity superagonist fusion protein of interleukin (IL)-15 and the IL-15 receptor α (IL-15Rα) sushi+ domain, representing a promising clinical candidate for the treatment of cancer • Exploring SO-C101 (RLI-15) as a monotherapy or in combination with pembrolizumab increases immune cell infiltration in tumors in clinically responsive patients in Phase…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.